136 related articles for article (PubMed ID: 3285227)
1. Effects of thromboxane synthase inhibitors on renal function.
Jackson EK; Goto F; Uderman HD; Workman RJ; Herzer WA; FitzGerald GA; Branch RA
Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):183-90. PubMed ID: 3285227
[TBL] [Abstract][Full Text] [Related]
2. Effects of thromboxane synthase inhibition on vascular responsiveness in the in vivo rat mesentery.
Jackson EK
J Clin Invest; 1985 Dec; 76(6):2286-95. PubMed ID: 4077980
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of prostaglandin I2 (PG I2) and thromboxane A2 (TXA2) synthetase inhibitor (OKY-1581) on hemodynamics in pregnant dogs.
Murayama K; Kasai H; Adachi T; Utsunomiya O; Ouchi H
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Mar; 35(3):344-50. PubMed ID: 6339650
[TBL] [Abstract][Full Text] [Related]
4. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.
Gentilini P; Laffi G; Meacci E; La Villa G; Cominelli F; Pinzani M; Buzzelli G
Gastroenterology; 1988 Jun; 94(6):1470-7. PubMed ID: 3360268
[TBL] [Abstract][Full Text] [Related]
5. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
Hatziantoniou C; Papanikolaou N
Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267
[TBL] [Abstract][Full Text] [Related]
6. The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction.
Loo MH; Egan D; Vaughan ED; Marion D; Felsen D; Weisman S
J Urol; 1987 Mar; 137(3):571-6. PubMed ID: 3820396
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046).
Hiraku S; Taniguchi K; Wakitani K; Omawari N; Kira H; Miyamoto T; Okegawa T; Kawasaki A; Ujiie A
Jpn J Pharmacol; 1986 Jul; 41(3):393-401. PubMed ID: 3093741
[TBL] [Abstract][Full Text] [Related]
8. Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamics in streptozotocin-induced diabetic rats.
Uriu K; Kaizu K; Hashimoto O; Komine N; Etoh S
Kidney Int; 1994 Mar; 45(3):794-802. PubMed ID: 8196281
[TBL] [Abstract][Full Text] [Related]
9. Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidney.
Goto F; Jackson EK; Ohnishi A; Herzer W; Branch RA
J Pharmacol Exp Ther; 1987 Dec; 243(3):799-803. PubMed ID: 3121844
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
[TBL] [Abstract][Full Text] [Related]
11. Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction.
Reyes AA; Klahr S
Proc Soc Exp Biol Med; 1991 Oct; 198(1):572-8. PubMed ID: 1891471
[TBL] [Abstract][Full Text] [Related]
12. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
[TBL] [Abstract][Full Text] [Related]
13. Role of thromboxane in control of arterial pressure and renal function in young spontaneously hypertensive rats.
Grone HJ; Grippo RS; Arendshorst WJ; Dunn MJ
Am J Physiol; 1986 Mar; 250(3 Pt 2):F488-96. PubMed ID: 3953827
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane mediates renal hemodynamic response to infused angiotensin II.
Wilcox CS; Welch WJ; Snellen H
Kidney Int; 1991 Dec; 40(6):1090-7. PubMed ID: 1837063
[TBL] [Abstract][Full Text] [Related]
15. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
de Chaffoy de Courcelles D; De Clerck F
Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
[TBL] [Abstract][Full Text] [Related]
16. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
[TBL] [Abstract][Full Text] [Related]
17. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic.
Welch WJ; Wilcox CS; Dunbar KR
Am J Physiol; 1989 Oct; 257(4 Pt 2):F554-60. PubMed ID: 2508488
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
19. Effect of thromboxane inhibition on renal blood flow in dogs with complete unilateral ureteral obstruction.
Loo MH; Marion DN; Vaughan ED; Felsen D; Albanese CT
J Urol; 1986 Dec; 136(6):1343-7. PubMed ID: 3464764
[TBL] [Abstract][Full Text] [Related]
20. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.
Ritter JM
Br J Pharmacol; 1984 Oct; 83(2):409-18. PubMed ID: 6386089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
